Seizures following subconjunctival 5-FU therapy.
Hoehn
René
R
Lamparter
Julia
J
Pfeiffer
Norbert
N
Vossmerbaeumer
Urs
U
D000368:Aged; D000477:Alkylating Agents / Q000008:administration & dosage; D000963:Antimetabolites / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003228:Conjunctiva / Q000187:drug effects; D005355:Fibrosis / Q000517:prevention & control; D005472:Fluorouracil / Q000009:adverse effects*; D005902:Glaucoma, Open-Angle / Q000601:surgery*; D006801:Humans; D007267:Injections; D007430:Intraoperative Care; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D012640:Seizures / Q000139:chemically induced*; D014130:Trabeculectomy
D000477:Alkylating Agents; D000963:Antimetabolites; D016685:Mitomycin; D005472:Fluorouracil